Danimer Scientific (DNMR) Tops Q3 EPS by 16c

Danimer Scientific (NYSE: DNMR) reported Q3 EPS of $0.08, $0.16 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $14.56 million.

Business Outlook:

The Company expects to continue its acceleration of investments in headcount, inclusive of Novomer, to build out the operational platform and infrastructure needed to support its production capacity expansion and sales growth objectives. The Company continues to expect that improved operating rates will contribute to Adjusted EBITDA and cash flow from operations. Based on the timing of customer product launches, the Company continues to expect its second half 2021 revenue to be weighted towards the fourth quarter. The Company now expects full year capital expenditures to be in the range of $200 million to $210 million mainly due to the accelerated groundbreaking of the Company’s greenfield facility in Bainbridge, Georgia as well as phase II construction moving faster than previously anticipated.

For earnings history and earnings-related data on Danimer Scientific (DNMR) click here.

You May Also Be Interested In

• GSX Techedu Inc. (GOTU) Misses Q2 EPS by 11c; offers guidance
• Kohl's (KSS) Tops Q2 EPS by 71c; raises guidance
• CrowdStrike Holdings Inc. (CRWD) Tops Q2 EPS by 2c, Beats on Revenue; Offers FY Guidance